Oracle Alpha »

Biogen Idec shares owned by Oracle Alpha

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Oracle Alpha from 13F filings

Historical chart of Oracle Alpha investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Oracle Alpha consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Oracle Alpha

Quarter filed Position value Share count Share price at filing
2023-12-31 $224k 865 258.77

More positions owned by Oracle Alpha

Micron Technology (MU)
Coinbase Global (COIN)
Eli Lilly & Co. (LLY)
Intel Corporation (INTC)
NVIDIA Corporation (NVDA)
Macy's (M)
Samsara (IOT)
Applied Materials (AMAT)
Synchrony Financial (SYF)
Gitlab (GTLB)
Ptc Therapeutics I (PTCT)
Netflix (NFLX)
Johnson & Johnson (JNJ)
Regeneron Pharmaceuticals (REGN)
Thermo Fisher Scientific (TMO)

View all positions for Oracle Alpha

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
Wellington Management Company
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
Van Eck Associates Corp.
Morgan Stanley
T. Rowe Price Associates
ClearBridge Advisors
Legal & General Group
Northern Trust
Bank of New York Mellon
Dimensional Fund Advisors

View all funds holding Biogen Idec